Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12088649rdf:typepubmed:Citationlld:pubmed
pubmed-article:12088649lifeskim:mentionsumls-concept:C0917727lld:lifeskim
pubmed-article:12088649lifeskim:mentionsumls-concept:C0019944lld:lifeskim
pubmed-article:12088649lifeskim:mentionsumls-concept:C2754943lld:lifeskim
pubmed-article:12088649lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:12088649lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:12088649lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:12088649lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:12088649lifeskim:mentionsumls-concept:C0445604lld:lifeskim
pubmed-article:12088649pubmed:issue1-2lld:pubmed
pubmed-article:12088649pubmed:dateCreated2002-6-28lld:pubmed
pubmed-article:12088649pubmed:abstractTextIn this study, IgG subclass responses against equine herpesvirus type 4 (EHV-4) were examined by enzyme-linked immunosorbent assay (ELISA) using a type-specific region of EHV-4 glycoprotein G (gG). ELISA using sera collected from horses experimentally infected with EHV-4 revealed that IgGa and IgGb antibodies were detected at high level, but IgGc and IgG(T) antibody responses were detected at low level or were undetectable. The IgGa antibody response reached its peak on day 10 post-infection, and then dropped. The IgGb antibody response reached its maximum level on day 12 post-infection, and then the level was sustained during at least 28 days after infection. Forty healthy racehorses that had already been infected with EHV-4 possessed antibody against EHV-4. Although IgGa antibodies specific for EHV-4 were not detected in any horses, IgGb antibodies were detected and the levels correlated with total IgG antibodies against EHV-4 gG. The results suggest that EHV-4-specific IgGa and IgGb antibodies are induced in EHV-4-infected horses, and that IgGb antibody, but not IgGa, is long lasting.lld:pubmed
pubmed-article:12088649pubmed:languageenglld:pubmed
pubmed-article:12088649pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12088649pubmed:citationSubsetIMlld:pubmed
pubmed-article:12088649pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12088649pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12088649pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12088649pubmed:statusMEDLINElld:pubmed
pubmed-article:12088649pubmed:monthSeplld:pubmed
pubmed-article:12088649pubmed:issn0165-2427lld:pubmed
pubmed-article:12088649pubmed:authorpubmed-author:KondoTakashiTlld:pubmed
pubmed-article:12088649pubmed:authorpubmed-author:MizukoshiFumi...lld:pubmed
pubmed-article:12088649pubmed:authorpubmed-author:MaedaKenKlld:pubmed
pubmed-article:12088649pubmed:authorpubmed-author:HamanoMasatak...lld:pubmed
pubmed-article:12088649pubmed:authorpubmed-author:IwataHiroyuki...lld:pubmed
pubmed-article:12088649pubmed:authorpubmed-author:MatsumuraTomi...lld:pubmed
pubmed-article:12088649pubmed:authorpubmed-author:SugiuraTakeoTlld:pubmed
pubmed-article:12088649pubmed:issnTypePrintlld:pubmed
pubmed-article:12088649pubmed:day6lld:pubmed
pubmed-article:12088649pubmed:volume88lld:pubmed
pubmed-article:12088649pubmed:ownerNLMlld:pubmed
pubmed-article:12088649pubmed:authorsCompleteYlld:pubmed
pubmed-article:12088649pubmed:pagination97-101lld:pubmed
pubmed-article:12088649pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12088649pubmed:meshHeadingpubmed-meshheading:12088649...lld:pubmed
pubmed-article:12088649pubmed:meshHeadingpubmed-meshheading:12088649...lld:pubmed
pubmed-article:12088649pubmed:meshHeadingpubmed-meshheading:12088649...lld:pubmed
pubmed-article:12088649pubmed:meshHeadingpubmed-meshheading:12088649...lld:pubmed
pubmed-article:12088649pubmed:meshHeadingpubmed-meshheading:12088649...lld:pubmed
pubmed-article:12088649pubmed:meshHeadingpubmed-meshheading:12088649...lld:pubmed
pubmed-article:12088649pubmed:meshHeadingpubmed-meshheading:12088649...lld:pubmed
pubmed-article:12088649pubmed:meshHeadingpubmed-meshheading:12088649...lld:pubmed
pubmed-article:12088649pubmed:meshHeadingpubmed-meshheading:12088649...lld:pubmed
pubmed-article:12088649pubmed:year2002lld:pubmed
pubmed-article:12088649pubmed:articleTitleIgG antibody subclass response against equine herpesvirus type 4 in horses.lld:pubmed
pubmed-article:12088649pubmed:affiliationDepartment of Veterinary Microbiology, Faculty of Agriculture, Yamaguchi University, Japan.lld:pubmed
pubmed-article:12088649pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12088649pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12088649lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12088649lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12088649lld:pubmed